Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Eng

Neurological Surgery Syracuse, NY Medical Doctor

NPI 1124029210 CMS profile 141287

739 Irving Ave Ste 600, Ste 600, Syracuse, NY 13210

Open in the dashboard

General payments

$13,358

400 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Eng of Syracuse, NY is reported in the CMS Open Payments database as having received $13,358 across 400 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,046 76
2024 General $3,745 77
2023 General $2,976 45
2022 General $832 48
2021 General $829 36
2020 General $454 40
2019 General $1,476 78

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Eng
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to David Eng were reported at $3,046. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year David Eng Neurological Surgery median Middle half National median
2019 $1,476 $582 $138–$3,006 $163
2020 $454 $294 $76–$2,174 $114
2021 $829 $387 $105–$2,432 $132
2022 $832 $542 $139–$2,989 $149
2023 $2,976 $534 $145–$2,697 $160
2024 $3,745 $574 $155–$3,046 $164
2025 $3,046 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $4,230 206 payments
  2. Alphatec Spine, Inc $2,810 4 payments
  3. Intrinsic Therapeutics $2,686 37 payments
  4. Medtronic USA, Inc. $1,688 115 payments
  5. SI-BONE, Inc. $464 4 payments
  6. Globus Medical, Inc. $334 7 payments
  7. Novocure Inc. $228 6 payments
  8. Boston Scientific Corporation $207 4 payments
  9. Xtant Medical Inc $151 1 payment
  10. Abbott Laboratories $138 2 payments
  11. Other $421 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,808 395 payments
  2. Travel and Lodging $3,200 4 payments
  3. Education $350 1 payment
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $2,810 4 payments
  2. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $2,686 37 payments
  3. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $2,686 37 payments
  4. PRESTIGE LP CERVICAL DISC SYSTEM $620 40 payments
  5. CATALYFT PL EXPANDABLE INTERBODY SYSTEM $517 37 payments
  6. PRESTIGE Cervical $429 9 payments
  7. ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY $419 25 payments
  8. PRESTIGE Cervical $342 30 payments
  9. MAZOR X SYSTEM $287 2 payments
  10. ELEVATE $257 21 payments
  11. Other $4,344 189 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$125,359

Medicare's payments for the services billed

Medicare patients

268

Average age 71

Services billed

926

162 women, 106 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 74%
High blood pressure 73%
Depression 32%
Diabetes 30%
Ischemic heart disease 22%
Osteoporosis 21%
Cancer 19%
Chronic kidney disease 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $9
$9 — —
Prolia
  • Amgen Inc. $9
$9 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

400 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record